Menu
The new sharewise is here Clearer, faster, with a light and a dark view — and everything you already know. Try it now
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

New Strong Sell Stocks for July 7th


Here are three stocks added to the Zacks Rank #5 (Strong Sell) List today:

Amprius Technologies, Inc. AMPX is a manufacturer of high-energy and high-power lithium-ion batteries with its Silicon Nanowire Anode Platform. The Zacks Consensus Estimate for its current year earnings has been revised almost 40% downward over the last 60 days.

Alpha Tau Medical DRTS is a medical device company, which focuses on research, development, and potential commercialization of the Alpha DaRT for the treatment of solid tumors. The Zacks Consensus Estimate for its current year earnings has been revised 34% downward over the last 60 days.

Bel Fuse BELFB designs, manufactures and markets a broad array of products that power, protect and connect electronic circuits. The Zacks Consensus Estimate for its current year earnings has been revised almost 7.3% downward over the last 60 days.

View the entire Zacks Rank #5 List.

7 Best Stocks for the Next 30 Days

Just released: Experts distill 7 elite stocks from the current list of 220 Zacks Rank #1 Strong Buys. They deem these tickers "Most Likely for Early Price Pops."

Since 1988, the full list has beaten the market more than 2X over with an average gain of +23.9% per year. So be sure to give these hand picked 7 your immediate attention. 

See them now >>

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report


 
Bel Fuse Inc. (BELFB): Free Stock Analysis Report
 
Alpha Tau Medical Ltd. (DRTS): Free Stock Analysis Report
 
Amprius Technologies, Inc. (AMPX): Free Stock Analysis Report

This article originally published on Zacks Investment Research (zacks.com).

Zacks Investment Research


Source Zacks-com

Like: 0
Share
At Zacks, we are dedicated to independent investment research, helping investors succeed through tools like our Zacks Rank stock-rating system, which has averaged +23.89% annual returns since 1988. Founded on the discovery that earnings estimate revisions drive stock prices, we offer purely mathematical, unbiased ratings, along with additional innovations like the Price Response Indicator, Earnings ESP, and specialized rankings for mutual funds and ETFs.
...
Legal notice

Comments